Results 151 to 160 of about 17,909 (286)

A structural and monetary perspective of the euro crisis [PDF]

open access: yes, 2016
BELLOFIORE, Riccardo   +2 more
openaire   +2 more sources

Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley   +1 more source

ANALISIS ABNORMAL RETURN SURAT BERHARGA PADA PENAWARAN PERDANA DI BURSA EFEK JAKARTA (PERBANDINGAN PERIODE SEBELUM DAN SELAMA KRISIS MONETER)

open access: yes, 2018
The research about abnormal return of initial offering has  been  carried out by many other researchers. The results indicated that underpricing which signed by positive abnormal returns occurred in the short time.
Pertiwi, Tri Kartika
core   +1 more source

Cost‐utility analysis of nusinersen–risdiplam switch in patients with spinal muscular atrophy in Croatia: A discrete event simulation model

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Introduction In recent years, the treatment of spinal muscular atrophy (SMA), a rare disease, has significantly progressed, improving patients' survival and overall quality of life. However, current SMA treatments are expensive, and some (nusinersen) are very inconvenient for patients.
Andrej Belančić   +4 more
wiley   +1 more source

DAMPAK KEBIJAKAN STRUKTURAL (STRUCTURAL ADJUSTMENT) INTERNATIONAL MONETARY FUND (IMF) DALAM PENANGANAN KRISIS MIONETER TAHUN 1997 TERHADAP KESEJAHTERAAN SOSIAL MASYARAKAT INDONESIA

open access: yes, 2007
The purpose of this research is to know the reason of Indonesia government ask the IMF to assist in handling monetary crisis in 1997. As everyone know that in handling of crisis, IMF accompanied by loan condition in the form of structural
Wijayati, Desi
core  

Beyond the label: Rethinking off‐label drug use in paediatrics. Towards a scientifically grounded and safer future for paediatric pharmacotherapy

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden   +3 more
wiley   +1 more source

Gi4SaveLife: a community-led model for sustainable voluntary blood donation in rural Sierra Leone. [PDF]

open access: yesBMJ Glob Health
Fernandez Turienzo C   +12 more
europepmc   +1 more source

Zuranolone: A case study in (regulatory) rush to judgement?

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Sage, in collaboration with Biogen, submitted a new drug approval for zuranolone for postpartum depression (PPD) and major depressive disorder (MDD) in December 2022. In August 2023, the US Food and Drug Administration granted approval for PPD but denied approval for MDD.
Lisa Cosgrove   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy